Are endothelin-receptor antagonists the preferred treatment for PAH associated with scleroderma?

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/50DFDBA3.svg?ark=w1%2F20260515%2F50DFDBA3)](https://nobleid.org/work/w1/20260515/50DFDBA3)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors